# Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn

> **NCT03162367** · PHASE2 · COMPLETED · sponsor: **SCARM Institute, Tabriz, Iran** · enrollment: 40 (actual)

## Conditions studied

- Burn

## Interventions

- **BIOLOGICAL:** Autologous epidermal cell suspension
- **DRUG:** Silver sulfadiazine ointment

## Key facts

- **NCT ID:** NCT03162367
- **Lead sponsor:** SCARM Institute, Tabriz, Iran
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162367, "Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03162367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*